Loading…
Taking Precise Aim at Lung Disease
[...]the more fitting terminology "precision health." To be suitable for use in routine clinical practice, biomarkers must be easy and quick to obtain, relatively inexpensive, minimally invasive, and reproducible across various treatments and populations. [...]biomarkers should be physiolo...
Saved in:
Published in: | American journal of respiratory and critical care medicine 2019-02, Vol.199 (3), p.255-256 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [...]the more fitting terminology "precision health." To be suitable for use in routine clinical practice, biomarkers must be easy and quick to obtain, relatively inexpensive, minimally invasive, and reproducible across various treatments and populations. [...]biomarkers should be physiologically relevant to the disease condition and able to predict relevant clinical outcomes with high accuracy. Surprisingly, inflammatory cells, proinflammatory cytokines, mucin production, and other factors strongly associated with airway remodeling- especially transforming growth factor-ß-were not increased in the airways of CC16-deficient mice, which casts some doubt on the suitability of the mouse model to recapitulate mechanisms at work in humans with obstructive lung disease. Something that works in the Tucson Children's Respiratory Study cohort may very well not be useful in other populations. [...]the results and conclusions of this study need to be replicated in subjects from diverse racial, sex, age, and environmental categories, and normative benchmarks need to be generated before CC16 can be considered for use in routine clinical practice. |
---|---|
ISSN: | 1073-449X 1535-4970 |
DOI: | 10.1164/rccm.201811-2117ED |